Top Stories
gbo-real-estate-award-winners

AI adoption in healthcare is surging, says experts

The survey result also indicates that confidence in AI is burgeoning, with two-thirds of the respondents believe that it has the potential to process medical records

Intel reports show that the percentage of healthcare companies which is currently-or will be- using AI has doubled since the outbreak of the pandemic. The company conducted an online survey comprising 200 senior leaders of different healthcare organisations in April, 2018 and again carried out the same this year with 230 senior leaders.

The results of the 2018 survey indicated that companies of the 37 percent of respondents have deployed AI or will deploy AI. Companies of the 45 percent of the respondents have already deployed AI prior to pandemic. The numbers climbed to 84 percent once the pandemic started.

The survey results also indicate that confidence in AI is burgeoning, with two-thirds of the respondents believing that it has the potential to process medical records seamlessly within two years. That said, 62 percent of the respondents believe that AI has the potential to process and analyse screening and diagnostics.

However, 20 percent of experts believe that cost would be the most difficult challenge to overcome, while 16 percent of them believe that AI is still in its nascent stage. The respondents also fear that if AI fails to perform well then it will cause a fatal error in results among other factors.

Stacey Shulman, vice president of the Internet of Things Group at Intel, said that AI implementation in industries will pave the path for clinicians to develop personalised protocols to streamlining clinical workloads and much more. AI is trending globally, not only in the field of healthcare, but in other sectors as well.

Related posts

Renewable energy segment’s growth surged last year amid the pandemic

GBO Correspondent

JP Morgan launches sustainable long-short fund worth $100 million

GBO Correspondent

AstraZeneca, Pfizer spur Covid-19 vaccine development

GBO Correspondent